Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Access to legal cannabis market in Canada over the four years following non‐medical cannabis legalisation
Daniel T. Myran, Erik Loewen Friesen, Sarah Dickson, et al.
Drug and Alcohol Review (2023) Vol. 42, Iss. 5, pp. 1114-1119
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Changes in Incident Schizophrenia Diagnoses Associated With Cannabis Use Disorder After Cannabis Legalization
Daniel T. Myran, Michael Pugliese, Lyndsay D. Harrison, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2457868-e2457868
Open Access | Times Cited: 2
The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review
Jakob Manthey, Britta M. Jacobsen, Tobias Hayer, et al.
International Journal of Drug Policy (2023) Vol. 116, pp. 104039-104039
Closed Access | Times Cited: 24
Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada
Daniel T. Myran, Adrienne Gaudreault, Lauren Konikoff, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336113-e2336113
Open Access | Times Cited: 22
Acute care related to cannabis use during pregnancy after the legalization of nonmedical cannabis in Ontario
Daniel T. Myran, Rhiannon Roberts, Michael Pugliese, et al.
Canadian Medical Association Journal (2023) Vol. 195, Iss. 20, pp. E699-E708
Open Access | Times Cited: 16
Germany's cannabis act: a catalyst for European drug policy reform?
Jakob Manthey, Jürgen Rehm, Uwe Verthein
The Lancet Regional Health - Europe (2024) Vol. 42, pp. 100929-100929
Open Access | Times Cited: 5
Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization
Daniel T. Myran, Adrienne Gaudreault, Michael Pugliese, et al.
JAMA Network Open (2023) Vol. 6, Iss. 9, pp. e2331551-e2331551
Open Access | Times Cited: 15
The ‘ban’ for public health that wasn't? Views and impressions on cannabis retail promotion/advertising realities amidst legalization policy in Canada
Benedikt Fischer
International Journal of Drug Policy (2024) Vol. 131, pp. 104294-104294
Closed Access | Times Cited: 4
Understanding youth and young adult cannabis use in Canada post-legalization: a scoping review on a public health issue
Toula Kourgiantakis, Ragave Vicknarajah, Judith Logan, et al.
Substance Abuse Treatment Prevention and Policy (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
The adverse public health effects of non-medical cannabis legalisation in Canada and the USA
Tesfa Mekonen Yimer, Eva Hoch, Benedikt Fischer, et al.
The Lancet Public Health (2025) Vol. 10, Iss. 2, pp. e148-e159
Open Access
Changes in population‐level alcohol sales after non‐medical cannabis legalisation in Canada
Michael J. Armstrong, Rachael MacDonald‐Spracklin, Jennifer Xiao, et al.
Drug and Alcohol Review (2025)
Open Access
Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization
Laurent Perrault‐Sequeira, Michael Pugliese, Rachael MacDonald‐Spracklin, et al.
American Journal on Addictions (2025)
Open Access
Exploring Associations between Cannabis Prices, Stores, and Usage after Recreational Legalization
Michael J. Armstrong
European Addiction Research (2025), pp. 1-8
Open Access
Cannabis consumers’ preferences for legal and illegal cannabis: evidence from a discrete choice experiment
Jin Xing, Yuyan Shi
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Exploring the role of primary regulation differences for cannabis legalization outcomes – preliminary data from two Canadian provinces
Tessa Robinson, Didier Jutras‐Aswad, Benedikt Fischer
Drugs Education Prevention and Policy (2024), pp. 1-7
Closed Access | Times Cited: 3
Youth cannabis use in Canada post-legalization: service providers’ perceptions, practices, and recommendations
Toula Kourgiantakis, Eunjung Lee, A. Kumsal Tekirdag Kosar, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 7
Individual differences in legal and illicit cannabis purchasing behaviour in British Columbia, Canada: Findings from a 2021 cross-sectional survey
Myles A. Maillet
International Journal of Drug Policy (2024) Vol. 126, pp. 104363-104363
Closed Access | Times Cited: 2
Primary crime-related outcome indicators associated with recreational cannabis legalization: a comprehensive literature and data review
Benedikt Fischer, Tessa Robinson, Hans‐Jörg Albrecht
Crime Law and Social Change (2024) Vol. 82, Iss. 3, pp. 685-715
Closed Access | Times Cited: 2
Are cannabis use problems comparable across individuals using for recreational and medical purposes? An international cross-sectional study of individuals who use self-grown cannabis
Sharon R. Sznitman, Gary Potter, Jodie Grigg, et al.
International Journal of Drug Policy (2023), pp. 104263-104263
Closed Access | Times Cited: 4
Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization
Daniel T. Myran, Adrienne Gaudreault, Michael Pugliese, et al.
Journal of Affective Disorders (2024) Vol. 351, pp. 853-862
Open Access | Times Cited: 1
Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study
Stephen D.S. McCarthy, Jennifer Xiao, Michael Pugliese, et al.
The Lancet Regional Health - Americas (2024) Vol. 36, pp. 100815-100815
Open Access | Times Cited: 1
Reducing the harms of cannabis use in youth post-legalization: insights from Ontario youth, parents, and service providers
Toula Kourgiantakis, Angie Hamilton, Christine Tait, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
How to interpret studies on the impact of legalizing cannabis
Jakob Manthey, Michael J. Armstrong, Tobias Hayer, et al.
Addiction (2023) Vol. 118, Iss. 11, pp. 2242-2243
Open Access | Times Cited: 4
Geographic clustering of cannabis stores in Canadian cities: A spatial analysis of the legal cannabis market 4 years post‐legalisation
Erik Loewen Friesen, Lauren Konikoff, Sarah Dickson, et al.
Drug and Alcohol Review (2024) Vol. 43, Iss. 7, pp. 1753-1763
Open Access
Changes in medical cannabis use in Ontario, Canada (2014 to 2019): Trajectory of trends, medical authorization patterns and association with recreational cannabis legalization
Sameer Imtiaz, Yeshambel T. Nigatu, Farihah Ali, et al.
Preventive Medicine Reports (2024) Vol. 44, pp. 102805-102805
Open Access
Barriers to scale: the effect of regulations on entrepreneurial strategies in a nascent industry
John McArdle, Alice J. de Koning, Arlinda Sherifi
Journal of Entrepreneurship and Public Policy (2024) Vol. 13, Iss. 4, pp. 618-647
Closed Access
Page 1 - Next Page

Scroll to top